Olajuyin Olaleye Ebenezer


  • Bachelor of Medical Laboratory Science (B.MLS), Ladoke Akintola University of Technology, Ogbomoso Nigeria


Cancer, Immunology/Inflammation/Hematology

Brief Biography

Olajuyin has over five years of experience studying biomedical science. His undergraduate thesis was focused on the comparative study of antioxidant enzymes and estrogen from women. He analyzed antioxidant enzymes, lipid peroxidation biomarkers, and estrogen to determine their predictive potential for cancer development. Olajuyin previously worked as a molecular scientist at APIN public health laboratory Makurdi, Nigeria, where he supported the treatment and care of HIV patients by carrying out Liver Function Tests and determining the viral load in the HIV+ blood samples using the Real Time-Polymerase Chain Reaction. He has a keen interest in cancer immunology and wishes to study the interaction between cancer cells and immune system cells and how this interaction can help in the design of anti cancer immunotherapeutic agents. His order area of interest includes molecular genetics, Tissue regeneration and Developmental Biology. Olajuyin is a strong advocate for Sustainable Development Goals (SDGs) 3 of the United Nation with much focus on cancer disease, its prevention, treatment and control.


  • Olajuyin OE, Ayeotan O, Ayinde SA, Olubiyi VT, Oke GI, Aluko SO. The Use of Immune System Cells for The Treatment of Metastatic Cancer: A Personalised Medicine Concept. J Clin Med Res. 2021;3(5):1-18.DOI: https://doi.org/10.37191/Mapsci-2582-4333-3(5)-084
  • Chibuike, A. C., Ferdinand, I. M., Ebenezer, O. O., Olorunfemi, A., Ajibade, E. F., Esther, I. I., Medugu, J. T., Agbecha, A., & Okwong, O. K. (2021). Serum Prostatic Specific Antigen Levels among Adult Male Patients Seen at Two Nigerian Tertiary Hospitals. Asian Journal of Research and Reports in Urology, 4(3), 25-30. Retrieved from https://www.journalajrru.com/index.php/AJRRU/article/view/30136
  • Ayeotan O, Hollands P, Olajuyin OE, Egbeleke FA, Oyemomi SS. The Incidence, Aetiology And Treatment of Leiomyoma in Nigeria. W J Gynecol Women’s Health. 4(4): 2020. WJGWH.MS.ID.000593. DOI: 10.33552/WJGWH.2020.04.000593.